Findings from the RVC indicate that stem cell therapy for superficial digital flexor tendon (SDFT) injury can significantly reduce the rate of re-injury over a three year period compared to conventionally treated horses.

To continue reading this article, become a member of TheHorse.com.

It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.

Sign In